Medical Bulletins

The Latest News on Infectious Disease Outbreaks Around the World

COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines

By Colin Schilly | February 12, 2021

In the second part of VIGILINT’s two-part series COVID-19 1 Year Later, VIGILINT Ops Analyst and blogger Colin Schilly dives into the two critical hallmarks of the pandemic. Testing and vaccines. The development and rollout of several effective vaccines in under a year offer great hope for the pandemic’s end. Sadly, that day may still… Read more about COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines

COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis

By Emily Elmore | February 4, 2021

On January 10, 2020, VIGILINT first reported a new strain of a coronavirus connected to a cluster of pneumonia cases linked to Wuhan, China. No one could have predicted the year that would follow. As of publishing, worldwide cases have reached 104 million with 2.27 million deaths. VIGILINT looks back at the critical events that… Read more about COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis

COVID-19 Transmission: Surfaces

By Alex Snyder | January 27, 2021

There is some risk of COVID-19 transmission from surfaces, but the primary disease transfer mode is airborne transmission. Several studies have analyzed the detection of COVID-19 on various surfaces. One such study, published by the New England Journal of Medicine in March 2020, largely shaped the discussion around SARS-COV-2 (the virus causing COVID-19 disease) transmissions… Read more about COVID-19 Transmission: Surfaces

COVID-19 Update: Vaccine Distribution

By Nick Debo | January 15, 2021

The Trump administration is reversing its COVID-19 vaccination strategy by authorizing the release of Pfizer-BioNtech and Moderna’s federally stockpiled vaccines. The previous policy withheld half the purchased doses to ensure the supply necessary for second doses, and states could only receive vaccines based on their adult population size. The new distribution strategy unveiled yesterday is intended… Read more about COVID-19 Update: Vaccine Distribution

VIGILINT Travel Notice: COVID-19 Testing for International Flights to the United States

By Intel & Marketing | January 14, 2021

COVID-19 TESTING FOR INTERNATIONAL FLIGHTS TO THE UNITED STATES 14 January 2021

COVID-19 VACCINE FACT SHEET

By Emily Elmore | January 13, 2021

COVID-19 VACCINES FAQ JAN13

COVID-19 Update: On the Single Deadliest Day of the Pandemic – LA County is Hardest Hit

By Alex Snyder and Nick Debo | January 8, 2021

The Situation in Los Angeles Yesterday was the single deadliest day of the pandemic with 4,000 deaths, and nowhere is harder hit than Los Angeles County. Cases have spiked drastically since December, with 809,052 cases and 10,739 deaths. Deaths were occurring every 8 minutes yesterday.  The California Department of Health rates LA county as Tier 1:… Read more about COVID-19 Update: On the Single Deadliest Day of the Pandemic – LA County is Hardest Hit

COVID-19 Update: Mutated Strain Found in Minks

By Alex Buckman and Emily Elmore | November 9, 2020

New SARS-CoV-2 Strain Found in Northern Europe’s Mink Population On November 5, 2020, Denmark reported 12 human cases of COVID-19 caused by a mutated SARS-CoV-2 strain carried by minks. Minks are a semi-aquatic mammal closely related to the weasel, otter, and ferret. Six other countries have reported outbreaks at mink farms including the Netherlands, Spain,… Read more about COVID-19 Update: Mutated Strain Found in Minks

COVID-19 Update: Convalescent Plasma

By Emily Elmore | August 27, 2020

On Sunday, August 23, the US Federal Food and Drug Administration (FDA) announced an Emergency Use Authorization (EUA) for convalescent plasma as a treatment for hospitalized COVID-19 patients citing “known and potential benefits of the product outweigh the known and potential risks of the product.” The EUA would effectively enable physicians to treat COVID-19 patients… Read more about COVID-19 Update: Convalescent Plasma

COVID-19 Update: The Race for a Vaccine

By Emily Elmore | July 28, 2020

Vaccine development for COVID-19 is topic number one, and our collective hope for going back to “normal” dangle on that needle. The global race to market includes pharma’s heavy hitters like Pfizer, Johnson & Johnson, AstraZeneca, and Moderna, a Cambridge, Massachusetts-based company that displayed hopeful results in Phase-1 trials and just this week received another… Read more about COVID-19 Update: The Race for a Vaccine

Monthly Newsletter

Featuring global health news from our Medical Intelligence Center

Sign Up!

Latest Blogs